论文信息 - Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study. - 字舞流文

Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study.

S. Woroniecki | S. Pröll | K. J. Drachenberg | E. Urban

[1] A. Wheeler,et al. Review of L‐tyrosine confirming its safe human use as an adjuvant , 2002, Journal of applied toxicology : JAT.

[2] Erkka Valovirta,et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.

[3] J Bousquet,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[4] S. Durham,et al. Immunologic changes associated with allergen immunotherapy. , 1998, The Journal of allergy and clinical immunology.

[5] Giorgio Walter Canonica,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases , 1998 .

[6] A. Wheeler,et al. Immunological adjuvants in allergy vaccines: Past, present and future , 2001 .

[7] A. Wheeler,et al. Chemical modification of crude timothy grass pollen extract. II. Class and specificity of antibodies induced by chemically modified timothy grass pollen extract. , 1976, International Archives of Allergy and Applied Immunology.